955362-51-3 Usage
Molecular Weight
340.49 g/mol
Functional Groups
Carbamate, tert-butyl, phenyl, ethylamino, and carbonothioyl
Tert-butyl group
A saturated carbon group with three methyl groups attached to a central carbon atom.
Carbamate functional group
An amide derived from carbonic acid, containing a carbon-oxygen single bond and a carbon-oxygen double bond.
Phenyl ring
A six-membered aromatic ring with alternating single and double carbon-carbon bonds.
Ethylamino carbonothioylamino group
A functional group containing an ethylamine (-NHCH2CH3) connected to a thiocarbonyl group (-C(S)-).
Pharmaceuticals
Due to its unique structure, it may have potential as a therapeutic agent or a precursor to other bioactive compounds.
Agrochemicals
It may be used as a component in the development of new pesticides or herbicides.
Research Needs
Further investigation is required to fully understand the compound's properties, stability, reactivity, and potential uses in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 955362-51-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,5,3,6 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 955362-51:
(8*9)+(7*5)+(6*5)+(5*3)+(4*6)+(3*2)+(2*5)+(1*1)=193
193 % 10 = 3
So 955362-51-3 is a valid CAS Registry Number.
955362-51-3Relevant academic research and scientific papers
COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE
-
Page/Page column 47, (2009/05/28)
The invention provides compounds of formula (I) and salts thereof wherein R1, R2, R3, R4 and X are as defined in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE
-
Page/Page column 48, (2008/06/13)
Compounds of formula (I), and salts and solvates thereof for use as a medicament are provided: (I) wherein R1, R2, R4, R10, X and Z are defined in the specification. Processes for preparation, pharmaceutical com
